510 results on '"Cameron, Michael D."'
Search Results
2. 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors
3. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents
4. Basolateral amygdala corticotropin releasing factor receptor 2 interacts with nonmuscle myosin II to destabilize memory in males
5. Probing a distinct druggable tubulin binding site with gatorbulins 1–7, their metabolic and physicochemical properties, and pharmacological consequences
6. Structure-based design of bitopic ligands for the µ-opioid receptor
7. Addressing the oxamniquine in vitro-in vivo paradox to facilitate a new generation of anti-schistosome treatments
8. An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer
9. SR9883 is a novel small-molecule enhancer of α4β2* nicotinic acetylcholine receptor signaling that decreases intravenous nicotine self-administration in rats.
10. Chemical systems biology reveals mechanisms of glucocorticoid receptor signaling
11. Synthesis and Evaluation of Oxyguanidine Analogues of the Cysteine Protease Inhibitor WRR-483 against Cruzain
12. Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model
13. Design of a small molecule that stimulates vascular endothelial growth factor A enabled by screening RNA fold–small molecule interactions
14. A G protein signaling-biased agonist at the μ-opioid receptor reverses morphine tolerance while preventing morphine withdrawal
15. Promoting activity of (α4)3(β2)2 nicotinic cholinergic receptors reduces ethanol consumption
16. Binding Mode and Potency of N‑Indolyloxopyridinyl-4-aminopropanyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51
17. Site-Selective Antibody Functionalization via Orthogonally Reactive Arginine and Lysine Residues
18. 4‑Aminopyridyl-Based CYP51 Inhibitors as Anti-Trypanosoma cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency
19. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents
20. M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer’s disease genes and improving memory
21. 1,3-diphenylureido hydroxamate: a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors
22. In vivo instability of platensimycin and platencin: Synthesis and biological evaluation of urea- and carbamate-platensimycin
23. Basolateral Amygdala Corticotrophin Releasing Factor Receptor 2 Interacts with Nonmuscle Myosin II to Destabilize Memory
24. Table S3 from Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor
25. Figure S1 from Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor
26. Data from Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor
27. Supplemental Methods from Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor
28. Data from A Novel HER2-Selective Kinase Inhibitor Is Effective in HER2 Mutant and Amplified Non–Small Cell Lung Cancer
29. Supplementary Data from A Novel HER2-Selective Kinase Inhibitor Is Effective in HER2 Mutant and Amplified Non–Small Cell Lung Cancer
30. Data from Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis
31. Supplementary Figure 6 from Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis
32. Supplementary Figure 4 from Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis
33. Supplementary Figure 8 from Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis
34. Supplementary Methods, Figure Legend from Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis
35. Supplementary Figure 3 from Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis
36. Supplementary Figure 2 from Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis
37. Supplementary Figure 7 from Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis
38. Supplementary Figure 5 from Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis
39. TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway
40. Design of a small molecule against an oncogenic noncoding RNA
41. Structure–Activity Relationship and Biological Investigation of a REV-ERBα-Selective Agonist SR-29065 (34) for Autoimmune Disorders.
42. Structure-based design of bitopic ligands for the µ-opioid receptor
43. Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma
44. Dual Inhibitors of Main Protease (MPro) and Cathepsin L as Potent Antivirals against SARS-CoV2
45. DNA-Encoded Library Screening To Inform Design of a Ribonuclease Targeting Chimera (RiboTAC)
46. Development of a putative Zn2+-chelating but highly selective MMP-13 inhibitor
47. Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance
48. Morphing Natural Product Platensimycin via Heck, Sonogashira, and One-Pot Sonogashira/Cycloaddition Reactions to Produce Antibiotics with In Vivo Activity
49. Insular Hypocretin Transmission Regulates Nicotine Reward
50. A Novel HER2-Selective Kinase Inhibitor Is Effective in HER2 Mutant and Amplified Non–Small Cell Lung Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.